Related Experiment Video
Updated: Apr 16, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Pathophysiology of venous thrombosis
1Department of Surgery, Section of Vascular Surgery, University of Michigan, Ann Arbor, USA Unit for Laboratory Animal Medicine, University of Michigan, Ann Arbor, USA ddmyers@umich.edu.
This chapter reviews key risk factors for venous thrombosis, including circulatory stasis, hypercoagulability, and endothelial damage. It highlights how age, gender, and obesity influence these prothrombotic mechanisms.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Pathophysiology
Background:
- Venous thrombosis pathophysiology is complex, involving Virchow's triad: circulatory stasis, hypercoagulability, and endothelial dysfunction.
- Risk factors such as increasing age, gender, and obesity significantly influence these prothrombotic mechanisms.
- Understanding these factors is crucial for managing and preventing venous thromboembolism.
Purpose of the Study:
- To provide an overview of prominent risk factors contributing to venous thrombosis.
- To discuss the historical context of Virchow's triad in understanding thrombosis.
- To highlight recent preclinical and clinical findings on prothrombotic mechanisms.
Main Methods:
- Literature review of historical and recent research on venous thrombosis.
- Discussion of preclinical investigations into prothrombotic mechanisms.
- Analysis of clinical studies examining risk factors and pathophysiology.
Main Results:
- Virchow's triad (stasis, coagulation changes, endothelial injury) remains central to thrombosis genesis.
- Age, gender, and obesity are identified as significant modulators of thrombosis risk.
- Recent research provides deeper insights into the molecular and cellular mechanisms driving thrombosis.
Conclusions:
- The pathophysiology of venous thrombosis is multifactorial, influenced by Virchow's original concepts and modern risk factors.
- Continued investigation into preclinical and clinical data is essential for advancing the understanding and treatment of venous thrombosis.
- Effective management strategies must address the interplay of genetic, environmental, and demographic factors contributing to thrombosis.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Varicose Veins I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins

